Author: Köster R. Kähler J. Brockhoff C. Münzel T. Meinertz T.
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.2, Iss.3, 2002-01, pp. : 197-207
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Coronary bypass cost effective, not so angioplasty
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 524, 2007-01 ,pp. :
Pharmacological Approaches to the Prevention of Restenosis After Coronary Angioplasty
By Hamon M.
Drugs & Aging, Vol. 13, Iss. 4, 1998-10 ,pp. :
Coumarin + aspirin cost saving for coronary angioplasty in The Netherlands
Inpharma, Vol. 1, Iss. 1357, 2002-01 ,pp. :
Bivalirudin preferable in coronary angioplasty?
Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. :
Coumarin + aspirin cost saving for coronary angioplasty in The Netherlands
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 382, 2002-01 ,pp. :